Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 8, Number 1—January 2002

Nosocomial Endocarditis Caused by Corynebacterium amycolatum and Other Nondiphtheriae Corynebacteria

Karen L. Knox*Comments to Author  and Alison H. Holmes†
Author affiliations: *St. George’s Hospital, London, United Kingdom; †Imperial College School of Medicine, Hammersmith Hospital, London, United Kingdom

Main Article

Table 1

Patient characteristics, heart valve affected, source of Corynebacterium infection and organism cultured, London

Case Age(y)/sex Underlying disease process Site of endocarditis Associated IIDa Therapy Outcome
1 74/F ANCA +
vasculitis Native mitral valve Vascular catheter
for HD Vancomycin i.v. + oral rifampicin,
16 monthsb Resolved
at 21 months
2 69/F ANCA +
vasculitis Native
mitral valve Gortex AV fistula,
vascular catheter
for HD Vancomycin i.v. + oral
37 days;
mitral valve replacement Died of unrelated
causes 9 weeks after diagnosis
3 53/M Postoperative
acute renal
failure Prosthetic
mitral valve
(Starr Edwards) Vascular catheter
for HD
CVC Vancomycin i.v. + oral
42 days Died of unrelated
causes 8.5 months postdiagnosis

aPatient refused surgery and follow-up echocardiograms.

bIID = indwelling intravascular device; ANCA = anti-neutrophil cytoplasmic antibody; HD = hemodialysis; AV = arteriovenous; CVC = central venous catheter.

Main Article

Page created: July 14, 2010
Page updated: July 14, 2010
Page reviewed: July 14, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.